跳至主要内容
临床试验/NL-OMON25665
NL-OMON25665已完成不适用

Improving CNS penetration of radiolabeled TKI PET tracers through PgP/BCRP inhibition

etherlands Cancer Institute - Antoni van Leeuwenhoek0 个研究点目标入组 8 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The study population consists of cancer patients with advanced or metastatic solid tumors for whom no standard
  • therapy is available or for whom a TKI which is a PgP/BCRP substrate is a standard therapeutic option (erlotinib,
  • sunitinib, imatinib, gefitinib, sorafenib, lapatinib, crizotinib, vemurafenib).

排除标准

  • - Known brain metastases;
  • - Patients who have had previous treatment with central nervous system irradiation;

研究者

发起方
etherlands Cancer Institute - Antoni van Leeuwenhoek

相似试验